Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
11/08/2011 | CA2415399C Use of strains of the parapox ovis virus against organ fibrosis |
11/08/2011 | CA2343414C Fc receptor modulators and uses thereof |
11/08/2011 | CA2302255C Fracture healing using pthrp analogs |
11/08/2011 | CA2247285C Human tumor necrosis factor delta and epsilon |
11/03/2011 | WO2011136585A2 Composition for treating bone disease comprising a glyceollin as an active ingredient |
11/03/2011 | WO2011136469A2 Pharmaceutical composition using connective tissue growth factor |
11/03/2011 | WO2011136378A1 Grafting material for genetic and cell therapy |
11/03/2011 | WO2011136308A1 Prophylactic or therapeutic agent for diseases associated with pains in urinary organs |
11/03/2011 | WO2011136292A1 Novel amide derivative and use thereof as medicine |
11/03/2011 | WO2011136264A1 [5,6] heterocyclic compound |
11/03/2011 | WO2011135969A1 Method for producing induced pluripotent stem cells |
11/03/2011 | WO2011135011A1 Treatment of cartilage resorption |
11/03/2011 | WO2011134971A1 7-(1h-pyrazol-4-yl)-1,6-naphthyridine compounds as syk inhibitors |
11/03/2011 | WO2011134101A1 New crystalline form n of febuxostat and preparation method thereof |
11/03/2011 | WO2011134084A1 Methods, compositions, and kits for the treatment of matrix mineralization disorders |
11/03/2011 | WO2011056037A3 Pharmaceutical composition containing, as active ingredients, lindera erythrocarpa extracts, fractions thereof, or compounds separated from the extracts |
11/03/2011 | US20110271358 Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor |
11/03/2011 | US20110269947 Apo-2 ligand/trail formulations |
11/03/2011 | US20110269842 Compositions comprising cb receptor agonists, uses thereof and methods for their preparation |
11/03/2011 | US20110269827 Use of lipoic acid for treating or preventing degenerative joint conditions, osteoarthritis, cartilage damage, and related disorders in companion animals |
11/03/2011 | US20110269811 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases |
11/03/2011 | US20110269810 Selective inhibitors of c-jun n-terminal kinase |
11/03/2011 | US20110269800 P38 map kinase inhibitors |
11/03/2011 | US20110269797 Anln protein as an endocrine treatment predictive factor |
11/03/2011 | US20110269790 Novel thienopyridines as pharmacologically active agents |
11/03/2011 | US20110269788 Spiro-oxindole-derivatives as sodium channel blockers |
11/03/2011 | US20110269787 Azabicyclic Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands |
11/03/2011 | US20110269769 Imidazole derivatives useful as inhibitors of faah |
11/03/2011 | US20110269763 CRTH2 receptor ligands for medicinal uses |
11/03/2011 | US20110269760 Tubulin inhibitors |
11/03/2011 | US20110269759 Pyrimidine compounds as delta opioid receptor modulators |
11/03/2011 | US20110269757 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
11/03/2011 | US20110269753 Heterocyclic compounds as phosphodiesterase inhibitors |
11/03/2011 | US20110269746 Cyclic compound having hetero atom |
11/03/2011 | US20110269740 Jak kinase modulating compounds and methods of use thereof |
11/03/2011 | US20110269739 Kinase inhibitors |
11/03/2011 | US20110269738 Compounds |
11/03/2011 | US20110269724 Combination Therapy with Non-Selective COX Inhibitors to Prevent COX-Related Gastric Injuries |
11/03/2011 | US20110269722 Prodrugs containing novel bio-cleavable linkers |
11/03/2011 | US20110269687 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants |
11/03/2011 | US20110269686 Cxcr4 antagonist and use thereof |
11/03/2011 | US20110269675 Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions |
11/03/2011 | US20110269668 Fused Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors |
11/03/2011 | US20110268820 Use of selective estrogen receptor modulator for joint fusion and other repair or healing of connective tissue |
11/03/2011 | US20110268815 Temperature-insensitive calcium phosphate cements |
11/03/2011 | US20110268801 Novel compounds and compositions and methods of use |
11/03/2011 | US20110268782 Polyurethanes for osteoimplants |
11/03/2011 | US20110268771 Chewable gelled emulsions |
11/03/2011 | US20110268735 Multimeric constructs |
11/03/2011 | US20110268733 ANTI-Siglec-15 ANTIBODY |
11/03/2011 | US20110268732 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof |
11/03/2011 | US20110268731 Methods of treating autoimmune disorders and/or inflammatory disorders |
11/03/2011 | US20110268730 Method for inhibiting bone resorption |
11/03/2011 | US20110268727 Anti-interferon-alpha antibodies |
11/03/2011 | US20110268725 Anti-NGF antibodies for the treatment of various disorders |
11/03/2011 | US20110268719 Annatto Extract Compositions, Including Geranyl Geraniols And Methods Of Use |
11/03/2011 | US20110268713 Variants of Ancestral Uricases and Uses Thereof |
11/03/2011 | US20110268708 Adipose tissue-derived stem cells for veterinary use |
11/03/2011 | US20110268706 Preparation method of porous hyaluronic acid sponge for cell delivery system |
11/03/2011 | US20110268695 Use of hmgb fragments as anti-inflammatory agents |
11/03/2011 | US20110268678 Vitamin d forming sunscreen |
11/03/2011 | US20110268666 Novel gastroretentive delivery system |
11/03/2011 | CA2797865A1 Methods, compositions, and kits for the treatment of matrix mineralization disorders |
11/03/2011 | CA2791020A1 [5,6] heterocyclic compound |
11/02/2011 | EP2383336A1 Peptide capable of binding to immunoglobulin |
11/02/2011 | EP2382206A2 Compounds and methods for the treatment of pain and other diseases |
11/02/2011 | EP2382202A1 Dihydropyridone amides as p2x7 modulators |
11/02/2011 | EP2381956A1 Treatment of soft tissue injury using hyaluronic acid and botulinum toxin |
11/02/2011 | EP2381948A2 Compounds and methods for enhancing erythropoiesis |
11/02/2011 | EP1615952B1 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
11/02/2011 | EP1425389B1 Human antibodies specific for interleukin 15 (il-15) |
11/02/2011 | CN102229658A Anti-rheumatoid arthritis polypeptide and its application in pharmacy |
11/02/2011 | CN102229657A Polypeptide against rheumatoid arthritis and application thereof in pharmacy |
11/02/2011 | CN102229656A Polypeptide against rheumatoid arthritis and application thereof in pharmacy |
11/02/2011 | CN102229655A Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy |
11/02/2011 | CN102229654A Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy |
11/02/2011 | CN102229653A Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy |
11/02/2011 | CN102229652A Polypeptide against rheumatoid arthritis and application thereof in pharmacy |
11/02/2011 | CN102229609A Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
11/02/2011 | CN102229589A N-{4'-substituted piperazine-1-sulfonylmethylalkyl}-N-hydroxyfomamide compounds as metalloproteinase inhibitors |
11/02/2011 | CN102229580A Novel pleuromutilin derivate, preparation method and medical use thereof |
11/02/2011 | CN102228653A Ethanol extract of galangal fruit and medical application thereof |
11/02/2011 | CN102228649A Quality control method for Shufeng Huoluo tablets |
11/02/2011 | CN102228594A Oxalis corymbosa and white flower tablet |
11/02/2011 | CN102228587A Traditional Chinese medicine preparation for treating bone fracture |
11/02/2011 | CN102228586A Ointment for promoting union of bone fractures and preparation method thereof |
11/02/2011 | CN102228585A Chinese medicinal preparation for treating lumbar interveterbral disc protrusion |
11/02/2011 | CN102228583A Chinese herbal composition and application thereof to preparing antirheumatic and antalgesic medicines |
11/02/2011 | CN102228578A Hot compress bag for rheumatism and related to sclerotin and manufacturing method thereof |
11/02/2011 | CN102228573A Application of Chinese medicines for diuresis to preparation of medicaments for preventing and treating osteoporosis |
11/02/2011 | CN102228556A Externally applied drug for fumigating treatment of arthritis |
11/02/2011 | CN102228553A Detection method of drug composition for treating rheumatoid arthritis |
11/02/2011 | CN102228528A Chinese medicinal preparation for treating arthritis |
11/02/2011 | CN102228523A Preparation method of total diterpenoid alkaloids from Delphinium Staphisagria |
11/02/2011 | CN102228512A Medicine for treating rheumatoid arthritis and preparation method thereof |
11/02/2011 | CN102228502A Medicinal wine for treating rheumatic-rheumatoid arthritis |
11/02/2011 | CN102228480A Application of propolis in Xuanwei and Caoba of Yunnan in medicine for promoting proliferation of osteoblast |
11/02/2011 | CN102228466A Chondroitin sulfate glucosamine tablets |
11/02/2011 | CN102228455A Application of bisbibenzyl compound to preparation of anti-inflammatory medicament |
11/02/2011 | CN102228441A Dexibuprofen sustained-release pellet and preparation method thereof |